ATE232748T1 - Hemmung von gefässverengungen nach eingriffen an den gefässen - Google Patents

Hemmung von gefässverengungen nach eingriffen an den gefässen

Info

Publication number
ATE232748T1
ATE232748T1 AT96915700T AT96915700T ATE232748T1 AT E232748 T1 ATE232748 T1 AT E232748T1 AT 96915700 T AT96915700 T AT 96915700T AT 96915700 T AT96915700 T AT 96915700T AT E232748 T1 ATE232748 T1 AT E232748T1
Authority
AT
Austria
Prior art keywords
matrix
cells
implanted
blood vessel
endothelial cells
Prior art date
Application number
AT96915700T
Other languages
English (en)
Inventor
Elazer Edelman
Aruna Nathan
Matthew A Nugent
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE232748T1 publication Critical patent/ATE232748T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96915700T 1995-06-02 1996-05-09 Hemmung von gefässverengungen nach eingriffen an den gefässen ATE232748T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/458,978 US5766584A (en) 1995-06-02 1995-06-02 Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
PCT/US1996/006707 WO1996038188A1 (en) 1995-06-02 1996-05-09 Inhibition of vascular occlusion following vascular intervention

Publications (1)

Publication Number Publication Date
ATE232748T1 true ATE232748T1 (de) 2003-03-15

Family

ID=23822888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915700T ATE232748T1 (de) 1995-06-02 1996-05-09 Hemmung von gefässverengungen nach eingriffen an den gefässen

Country Status (8)

Country Link
US (1) US5766584A (de)
EP (1) EP0850073B1 (de)
JP (2) JP3941881B2 (de)
AT (1) ATE232748T1 (de)
AU (1) AU714559B2 (de)
CA (1) CA2222497C (de)
DE (1) DE69626290T2 (de)
WO (1) WO1996038188A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435002T2 (de) 1993-07-19 2008-03-20 Angiotech Pharmaceuticals, Inc., Vancouver Anti-angiogene Mittel enthaltend Taxol und einen nicht biodegradierbaren Träger und deren Verwendung
WO1997045105A1 (en) 1996-05-24 1997-12-04 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing diseases of body passageways
US20020077564A1 (en) * 1996-07-29 2002-06-20 Farallon Medsystems, Inc. Thermography catheter
US20080305999A1 (en) * 1996-11-01 2008-12-11 John Francis Martin Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
US20040015069A1 (en) * 1996-12-27 2004-01-22 Brown David Lloyd System for locating inflamed plaque in a vessel
GB9809082D0 (en) * 1998-04-28 1998-06-24 Eurogene Limited Delivery device
US20030039694A1 (en) * 1998-04-28 2003-02-27 Martin John Francis Periadventitial delivery device
US6375680B1 (en) * 1998-12-01 2002-04-23 St. Jude Medical, Inc. Substrates for forming synthetic tissues
US20040097990A1 (en) * 1999-01-27 2004-05-20 Zhao Iris Ginron Graft material, device & method of making
US6824549B1 (en) * 2000-06-07 2004-11-30 Iris Ginron Chao Method & device for making reversed bypass with cultured vessel in situ
US6333347B1 (en) 1999-01-29 2001-12-25 Angiotech Pharmaceuticals & Advanced Research Tech Intrapericardial delivery of anti-microtubule agents
US6328762B1 (en) 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6921412B1 (en) 1999-05-18 2005-07-26 Cryolife, Inc. Self-supporting, shaped, three-dimensional biopolymeric materials and methods
JP3603179B2 (ja) 1999-09-09 2004-12-22 グンゼ株式会社 心血管系組織培養用基材および組織再生法
JP2003520830A (ja) * 2000-01-25 2003-07-08 エドワーズ ライフサイエンシーズ コーポレイション 再狭窄および吻合内膜過形成処置のための送達系
AU2002215387B2 (en) * 2000-10-24 2005-09-29 Cryolife, Inc. In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics
US20040241211A9 (en) * 2000-11-06 2004-12-02 Fischell Robert E. Devices and methods for reducing scar tissue formation
US7226615B2 (en) * 2000-11-07 2007-06-05 Cryolife, Inc. Expandable foam-like biomaterials and methods
EP1351681B1 (de) * 2001-01-16 2010-09-15 Vascular Therapies, LLC Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
JP3970013B2 (ja) * 2001-12-14 2007-09-05 泰晴 野一色 管腔形成誘導性材料および体内挿入用器具
AU2003228808A1 (en) * 2002-05-02 2003-11-17 Regents Of The University Of Minnesota Fibrin-based biomatrix
JP4265888B2 (ja) * 2002-06-12 2009-05-20 株式会社リコー 画像形成装置
AU2004226327A1 (en) 2003-03-28 2004-10-14 Innovational Holdings, Llc Implantable medical device with beneficial agent concentration gradient
US8034048B2 (en) * 2003-05-05 2011-10-11 Boston Scientific Scimed, Inc. Tissue patches and related delivery systems and methods
US7416546B2 (en) * 2003-05-05 2008-08-26 Boston Scientific Scimed, Inc. Tissue patches and related delivery systems and methods
US8192348B2 (en) * 2003-07-01 2012-06-05 Regents Of The University Of Minnesota Engineered blood vessels
WO2005007034A1 (en) * 2003-07-08 2005-01-27 The Children's Hospital Of Philadelphia Steroid lipid-modified polyurethane as an implantable biomaterial, the preparation and uses thereof
WO2005037144A2 (en) * 2003-10-10 2005-04-28 Cellular Bioengineering, Inc. Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
US20050245905A1 (en) * 2004-04-30 2005-11-03 Schmidt Steven P Local drug-delivery system
AU2011211370B2 (en) * 2004-12-08 2013-08-15 Shire Regenerative Medicine, Inc. Methods and compositions for enhancing vascular access
DE602005022481D1 (de) * 2004-12-08 2010-09-02 Pervasis Therapeutics Inc Zusammensetzungen und deren verwendung für besseren gefässzugang
JP5174656B2 (ja) 2005-04-21 2013-04-03 マサチューセッツ インスティテュート オブ テクノロジー 同系または非同系の細胞、組織または器官を含む、外因性免疫原および内因性免疫原に対する免疫応答を改変するための材料および方法
US20090035346A1 (en) * 2005-06-21 2009-02-05 Pervasis Therpeutics, Inc. Methods and Compositions for Enhancing Vascular Access
US20070100323A1 (en) * 2005-10-31 2007-05-03 Ludwig Florian N Facilitation of endothelialization by in situ surface modification
US20100204783A1 (en) * 2005-12-06 2010-08-12 Helen Marie Nugent Methods and compositions for enhancing vascular access
CA2668621A1 (en) * 2006-11-07 2008-05-15 Pervasis Therapeutics, Inc. Materials and methods for treating and managing angiogenesis-mediated diseases
US20080176206A1 (en) 2007-01-18 2008-07-24 Toshiharu Shinoka Cardiovascular tissue culture substrate
US20100185156A1 (en) * 2007-06-13 2010-07-22 Pervasis Therapeutics, Inc. Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions
US20100239671A1 (en) 2007-11-06 2010-09-23 Edelman Elazer R Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair
US20110218606A1 (en) * 2010-03-02 2011-09-08 Medtronic Vascular, Inc. Methods for Stabilizing Femoral Vessels
US9114235B2 (en) 2010-05-03 2015-08-25 Cardiovascular Systems, Inc. Therapeutic agent delivery system and method for localized application of therapeutic substances to a biological lumen
FR2960784B1 (fr) 2010-06-04 2012-07-20 Univ Claude Bernard Lyon Nouveaux substituts vasculaires biodegradables
US9198975B2 (en) 2010-12-01 2015-12-01 The University Of North Carolina At Chapel Hill Methods and compositions for targeting sites of neovascular growth
CN111454467B (zh) * 2020-02-18 2022-07-12 中国人民大学 一种涂抹式生物可降解血管外支架及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
IL78950A (en) * 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
AU6747790A (en) * 1989-11-13 1991-06-13 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
CA2113089C (en) * 1991-07-15 2007-11-06 Peter J. Sims Universal donor cells
US5336615A (en) * 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
EP0757562A1 (de) * 1994-04-29 1997-02-12 W.L. Gore & Associates, Inc. Blutkontaktoberfläche unter verwendung von endothel auf einer subendotelialen extrazellulären matrix

Also Published As

Publication number Publication date
AU6292896A (en) 1996-12-18
DE69626290T2 (de) 2003-12-04
AU714559B2 (en) 2000-01-06
EP0850073B1 (de) 2003-02-19
DE69626290D1 (de) 2003-03-27
CA2222497C (en) 2008-07-29
WO1996038188A1 (en) 1996-12-05
US5766584A (en) 1998-06-16
CA2222497A1 (en) 1996-12-05
JP2005254000A (ja) 2005-09-22
EP0850073A1 (de) 1998-07-01
JPH11506364A (ja) 1999-06-08
JP3941881B2 (ja) 2007-07-04

Similar Documents

Publication Publication Date Title
ATE232748T1 (de) Hemmung von gefässverengungen nach eingriffen an den gefässen
Chocarro‐Wrona et al. Therapeutic strategies for skin regeneration based on biomedical substitutes
Lynn et al. Characterization of the in vitro macrophage response and in vivo host response to poly (ethylene glycol)‐based hydrogels
Jansen et al. A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous tissue reactions, and degradation in the rat
Ingram et al. The use of ultrasonication to aid recellularization of acellular natural tissue scaffolds for use in anterior cruciate ligament reconstruction
Dunn et al. Development of fibroblast‐seeded ligament analogs for ACL reconstruction
Keilhoff et al. Bio-compatibility of type I/III collagen matrix for peripheral nerve reconstruction
Chu et al. Enhanced growth of animal and human endothelial cells on biodegradable polymers
Powell et al. EDC cross-linking improves skin substitute strength and stability
Isenberg et al. Small-diameter artificial arteries engineered in vitro
EP1546307B1 (de) Zellen auf matrixunterlagen für die wiederherstellung von geweben
MANSKE et al. Histologic Evidence of Intrinsic Flexor Tendon Repair in Various Experimental Animals An In Vitro Study
Eweida et al. Naturally occurring extracellular matrix scaffolds for dermal regeneration: do they really need cells?
ES2004281A6 (es) Una superficie protesica implantable para implantacion en un paciente humano
WO1998054301B1 (en) Transplants for myocardial scars and method and cellular preparations therefor
ES8900149A1 (es) Un metodo para tratar una protesis implantable, destinada a ser implantada en un paciente humano
Tiwari et al. Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate
CA2954989A1 (en) Tissue graft comprising a gel with a biostucture contained therin
CA2432416A1 (en) Method of creating biological and biosynthetic material for implantation
Kangesu et al. A porcine model using skin graft chambers for studies on cultured keratinocytes
Lei et al. Research on alginate-polyacrylamide enhanced amnion hydrogel, a potential vascular substitute material
US9259445B2 (en) Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure
Auger et al. Role and innocuity of Tisseel®, a tissue glue, in the grafting process andin vivo evolution of human cultured epidermis
Fimiani et al. Other uses of homologous skin grafts and skin bank bioproducts
CN103933619A (zh) 神经修复材料及其制备方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties